In the study by Giri, K. et al., SMR3B was identified as a salivary biomarker whose specific peptides (GPYP/IPPP), combined with other protein markers, effectively distinguished triple-negative breast cancer patients (80% sensitivity, 95% specificity), though its precise biological mechanisms remain unclear (45). Here, SMR3B is linked to triple-negative breast carcinoma.